Key result
Gut microbiota signatures linked to long-term mortality, diabetes, liver disease, and sepsis risk.
Why the study?
The overall robustness, generalizability, and prospective potential of gut microbiota enterosignatures in predicting long-term health status remained to be evaluated.
Do gut microbiota signatures predict long-term health status (mortality, diabetes, liver disease, sepsis) in Finnish adults?
Cohort
Do gut microbiota signatures predict long-term health status (mortality, diabetes, liver disease, sepsis) in Finnish adults?
Specific gut microbiota signatures can prospectively predict long-term risks of mortality, diabetes, liver disease, and sepsis over 20 years.
Microbiota signatures may inform future risk models; leaves open incremental value and generalizability pending validation trials.
MOTIVATION: The human gut microbiota is a complex ecosystem composed of hundreds of unique microbial species in a typical adult individual. Its composition has been linked to an individual's current and future health. At the population level, joint analysis of co-abundant species can capture associations with health status and other variables that cannot be robustly detected by analyzing individual taxa alone. Recently, the concept of enterosignatures was proposed to detect such co-abundant groups, decomposing microbial community variation into a mixture of five broad components of co-varying microbial taxa. However, their overall robustness, generalizability, and prospective potential in predicting long-term health status remain to be evaluated. RESULTS: We demonstrate that robust signatures of co-abundant species can be prospectively associated with mortality, diabetes, liver disease, and sepsis risk among Finnish adults in the FINRISK population cohort based on a 20-year follow-up. We characterized dysbiosis-associated signatures across varying levels of sub-ecosystem granularity, encompassing a previously reported Escherichia-driven signature as well as novel Prevotella subspecies-driven signatures linked to compromised future health status. These results illustrate the benefits of analyzing latent signatures across multiple levels of ecosystem granularity.
No takes yet. Share an insight, caveat, or question.
Lindgren et al. (2026) conducted a cohort in General population. Gut microbiota signatures was evaluated on Mortality, diabetes, liver disease, and sepsis risk. Gut microbiota signatures of co-abundant species were prospectively associated with mortality, diabetes, liver disease, and sepsis risk over a 20-year follow-up in Finnish adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: